Immunologic, inflammatory, and allergic diseases place a substantial burden on patients, driven by complex and interconnected immune pathways that extend across multiple organs and disease states. Advances in immunology are transforming our understanding of disease and enabling innovative therapies with potential across a wide range of conditions, yet significant unmet need remains and clinical development continues to grow in complexity. OptimaImmuno Suite, Optimapharm’s integrated clinical trial platform, applies this evolving science to the therapeutic areas where we focus most deeply - including infectious disease, oncology, dermatology, gastroenterology, rheumatology, allergy, and respiratory. By uniting high-performing sites, experienced medical experts, advanced technology, and engaged patients, we streamline programs with broad indication potential and deliver more efficient, high-quality clinical trials.
Respiratory
Infectious Disease
Dermatology
Allergy
Rheumatology
Gastroenterology
Oncology
Dr. Pavle Vukojević
Chief Medical Officer
Pavle Vukojević is a seasoned clinical research professional with extensive experience spanning multiple functional areas of the industry and a broad spectrum of therapeutic fields and indications. As an Internal Medicine specialist – Rheumatologist with a master’s degree in Immunology, his primary medical and scientific expertise focuses on clinical research in autoimmune diseases, as well as innovative immunotherapy strategies across diverse therapeutic areas
Patient Advisory Board
Optimapharm has established a dedicated Patient Advisory Board, which we actively collaborate with and support to ensure patients' perspectives are reflected throughout development. By embedding their voice into clinical trial protocols and study execution, we help shape research that is more accessible, meaningful and aligned with the needs of those it aims to serve
We Proudly Support
Site & Patient Referral Networks
Optimapharm strategically partners with diverse site networks, including community-based recruitment organisations, site management organisations, and leading hospital systems, to deliver faster and more seamless study execution. With twice the reach across North America and Europe compared with the average mid-sized CRO, we expand access to patients where they live and receive care, enabling broader enrolment and real-world representation. These collaborative partnerships drive accelerated start-up, stronger referral pathways and a consistently high-performing site experience.
2xThe reach of the average mid-sized CRO in North America and Europe
Accelerating delivery through patient reach and expanded access to regulatory frameworks
Data Visualisations
BI Wizard is our custom-built analytics solution, developed and powered by Microsoft Power BI. It leverages Power BI's robust business intelligence platform to visualise data, share insights, and provide interactive dashboards and reports. With BI Wizard, both Optimapharm and our sponsors can easily explore and interact with data, supporting informed, data-driven decision-making on all sides
Operational Insights
Example Report (Enrolment)
Patient Profiling
Example Report (Blood Pressure)